Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)9.83
  • Today's Change0.038 / 0.38%
  • Shares traded14.46k
  • 1 Year change+47.34%
  • Beta1.6292
Data delayed at least 15 minutes, as of Nov 08 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of DKK
(except for per share items)
Fiscal data as of Dec 31 202320232022
OPERATIONS
Net income1,475(347)
Depreciation/depletion1,112399
Non-Cash items83326
Cash taxes paid, supplemental103.21
Cash interest paid, supplemental5224
Changes in working capital(1550)(158)
Total cash from operations1,119220
INVESTING
Capital expenditures(977)(1382)
Other investing and cash flow items, total32504
Total cash from investing(946)(877)
FINANCING
Financing cash flow items(43)(0.11)
Total cash dividends paid----
Issuance (retirement) of stock, net1,67829
Issuance (retirement) of debt, net(900)607
Total cash from financing736636
NET CHANGE IN CASH
Foreign exchange effects(7.65)5.12
Net change in cash902(16)
Net cash-begin balance/reserved for future use575592
Net cash-end balance/reserved for future use1,477575
SUPPLEMENTAL INCOME
Depreciation, supplemental1,112399
Cash interest paid, supplemental5224
Cash taxes paid, supplemental103.21
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.